Author name: Neurad Diagnostic

A palpable lump, a suspicious thyroid nodule on scan, an enlarged lymph node, or a breast mass seen on mammography — all of these require tissue sampling for definitive diagnosis. The USG Guided FNAC and Biopsy service at Neurad Diagnostics in Delhi provides the most direct, safe, and accurate route to tissue diagnosis for superficial and ultrasound-visible lesions. Using real-time high-resolution ultrasound to guide needle placement with pinpoint precision, our experienced team delivers highly accurate tissue samples while minimizing patient discomfort and risk. This comprehensive guide explains everything about this procedure and Biopsy in Delhi. According to the American College of Radiology (ACR), ultrasound-guided FNAC and biopsy are the recommended standard for sampling thyroid nodules, lymph nodes, and superficial masses. The American Thyroid Association (ATA) guidelines specifically recommend ultrasound-guided FNAC for all thyroid nodules meeting biopsy criteria. ultrasound guided biopsy at Neurad Diagnostics Delhi — Real-time ultrasound-guided tissue sampling Table of Contents What Is USG Guided FNAC and Biopsy? USG Guided FNAC vs. Core Needle Biopsy Why Doctors Recommend USG Guided FNAC and Biopsy Organs and Lesions Diagnosed by USG Guided FNAC and Biopsy Who Needs USG Guided FNAC or Biopsy? Symptoms That Lead to USG Guided FNAC and Biopsy How this test and Biopsy Works Preparation Before USG Guided FNAC and Biopsy Step-by-Step the FNAC Procedure at Neurad Diagnostics Advantages of Ultrasound Guided Tissue Sampling Accuracy and Success Rate Safety and Complication Profile Cost of USG Guided FNAC and Biopsy in Delhi NCR Why Choose Neurad Diagnostics for USG Guided FNAC and Biopsy in Delhi? Frequently Asked Questions About ultrasound guided biopsy and Biopsy 1. What is the difference between USG guided FNAC and blind FNAC? 2. Is ultrasound guided FNAC of thyroid painful? 3. How many needle passes are needed in USG guided FNAC? 4. Can USG guided biopsy detect lymphoma? 5. Do I need to rest after the FNAC? 6. Can ultrasound guided biopsy be done for breast cancer? 7. What happens to the tissue sample after USG guided biopsy? 8. Is breast core biopsy better than surgical biopsy? 9. Can I get FNAC and biopsy done on the same day? 10. Where can I get USG guided FNAC biopsy near me in Delhi NCR? Conclusion — Book Your USG Guided FNAC / Biopsy at Neurad Diagnostics Delhi What Is USG Guided FNAC and Biopsy? this test (Ultrasound Guided Fine Needle Aspiration Cytology) and USG Guided Core Needle Biopsy are interventional procedures that use real-time ultrasound imaging to precisely guide a needle to a target lesion for tissue sampling. Ultrasound guidance allows the radiologist to see the needle tip in real time as it approaches the target lesion, ensuring accurate sampling while avoiding blood vessels and critical structures. Compared to CT guidance, ultrasound guidance has the advantage of being completely radiation-free, more cost-effective, and highly efficient for superficial or intra-abdominal lesions that are well-visualized on ultrasound. It is the guidance method of choice for thyroid nodules, lymph nodes, breast masses, liver lesions, and other superficial/ultrasound-visible structures. At Neurad Diagnostics in Delhi, USG guided procedures are performed by highly experienced interventional radiologists using state-of-the-art high-resolution ultrasound systems. USG Guided FNAC vs. Core Needle Biopsy Understanding the difference between these two procedures helps patients and physicians choose the right approach: the FNAC: Uses a very thin needle (22-25 gauge, the size of a standard blood draw needle) to aspirate a small number of cells from the lesion. This is a cytological procedure — the aspirated cells are spread on glass slides and examined by a cytopathologist. FNAC is very quick, minimally invasive, requires no anaesthesia (or minimal local anaesthesia), and has an excellent safety profile. It is ideal for thyroid nodules, superficial lymph nodes, parotid gland, breast masses (especially cysts), and soft tissue lesions. The main limitation is that it provides only cellular material, which may be insufficient for diagnoses requiring tissue architecture assessment or extensive molecular profiling. USG Guided Core Needle Biopsy (CNB): Uses a spring-loaded cutting needle (14-20 gauge) to obtain a small core of tissue that preserves the architecture of the lesion. This is a histopathological procedure — the tissue core is processed, sectioned, and stained for examination. CNB provides material suitable for IHC, receptor profiling (ER/PR/HER2 for breast), molecular mutation testing (EGFR, ALK for lung), and lymphoma subtyping. It requires local anaesthesia but is still an outpatient, day-care procedure. CNB is preferred for breast cancer (ER/PR/HER2 profiling), liver biopsies, lymphoma, and any situation requiring molecular characterization. Why Doctors Recommend USG Guided FNAC and Biopsy Endocrinologists, oncologists, surgeons, and other specialists recommend the procedure and Biopsy in Delhi because ultrasound guidance transforms what would otherwise be a blind or inaccurate sampling attempt into a precise, visualized, and reliable procedure. For thyroid nodules specifically, blind aspiration carries a significantly higher inadequate sample rate than ultrasound guided FNAC — which has become the universal standard of care. For breast lesions, ultrasound guided core biopsy has replaced most open surgical biopsies, reducing patient morbidity dramatically. In modern oncology, the shift toward precision medicine means that tissue diagnosis must provide not just a cancer confirmation but a complete molecular characterization — receptor status, mutation profile, PD-L1 expression — to guide targeted therapy selection. Ultrasound guided core needle biopsy provides the high-quality tissue samples necessary for this comprehensive molecular testing at Neurad Diagnostics in Delhi. Organs and Lesions Diagnosed by USG Guided FNAC and Biopsy Thyroid Nodules: this procedure is the standard evaluation for thyroid nodules ≥ 1 cm (per ATA/TIRADS guidelines) Lymph Nodes: Cervical, axillary, inguinal, and intra-abdominal lymph nodes Breast Masses: Palpable and non-palpable (detected on mammography or breast ultrasound) Liver Lesions: Hepatocellular carcinoma, metastases, benign lesions Kidney Lesions: Renal cell carcinoma, complex cysts Salivary Gland Lesions: Parotid, submandibular gland masses Soft Tissue Masses Pancreatic lesions (with endoscopic ultrasound or when transabdominal access possible) Superficial muscle and subcutaneous lesions Scrotal and testicular lesions Pleural lesions and effusions Who Needs USG Guided FNAC or Biopsy? Your doctor may refer you for ultrasound guided biopsy or Biopsy in Delhi in

When imaging studies reveal a suspicious lesion or mass in the body, the definitive next step is usually a biopsy — obtaining a tissue sample for pathological analysis. The CT Guided Biopsy, available at Neurad Diagnostics in Delhi, is one of the most accurate, safe, and minimally invasive methods for obtaining tissue from lesions deep inside the body that cannot be reached safely by other means. Whether it is a lung nodule, liver mass, abdominal lymph node, or spinal lesion, this procedure allows our expert interventional team to deliver a precise needle to the exact target — without major surgery. This guide explains everything patients need to know about the biopsy and FNAC in Delhi. According to the Society of Interventional Radiology (SIR), CT guided biopsy is a safe and highly effective procedure for tissue diagnosis across all body regions. The Radiological Society of North America (RSNA) endorses image-guided biopsy as the standard of care for accessible lesion sampling. this test at Neurad Diagnostics Delhi — Precision tissue sampling under CT guidance Table of Contents What Is core needle biopsy? this procedure vs. CT Guided FNAC Why Doctors Recommend CT Guided Biopsy Conditions Diagnosed by this test Who Needs CT Guided Biopsy? Symptoms and Findings That Lead to the procedure How CT Guided Biopsy Works Preparation Before this procedure Step-by-Step the biopsy Procedure at Neurad Diagnostics Advantages of CT Guided Biopsy Accuracy and Success Rate Safety and Complication Profile Cost of CT Guided Biopsy in Delhi NCR Why Choose Neurad Diagnostics for CT Guided Biopsy in Delhi? Frequently Asked Questions About this test 1. Is CT guided biopsy the same as a surgical biopsy? 2. Can CT guided biopsy be done for any body part? 3. Will I need to stop blood thinners before the biopsy? 4. How long will I be at the hospital/center for this procedure? 5. When will I get the biopsy results? 6. Is the biopsy suitable for lung nodules? 7. Can this test diagnose tuberculosis? 8. Does CT guided biopsy cause cancer to spread? 9. Can I eat after the procedure? 10. Where can I get this procedure near me in Delhi NCR? Conclusion — Book Your the biopsy at Neurad Diagnostics Delhi What Is core needle biopsy? CT Guided Biopsy is an interventional radiology procedure in which real-time CT (Computed Tomography) imaging is used to precisely navigate a biopsy needle to a target lesion within the body. The interventional radiologist uses serial CT images to visualize the exact position of the needle tip in relation to the target lesion and surrounding critical structures, adjusting its trajectory in real time until the needle is optimally positioned. A tissue core sample (biopsy) or fine needle aspirate (FNAC) is then obtained from the lesion for pathological analysis. CT guidance is particularly valuable for accessing lesions that are deep within the body, are not visible on ultrasound, are located near critical structures (blood vessels, nerves), or require very precise needle placement for safety. Lesions in the lung, liver, pancreas, kidney, adrenal gland, retroperitoneum, spine, mediastinum, and bone are commonly biopsied under CT guidance. At Neurad Diagnostics in Delhi, our experienced interventional team performs the procedure as a same-day, outpatient or short-stay procedure. this procedure vs. CT Guided FNAC Two types of needle sampling are performed under CT guidance at Neurad Diagnostics: CT Guided FNAC (Fine Needle Aspiration Cytology) uses a very thin needle (22-25 gauge) to aspirate a small number of cells from a lesion. It is less invasive and carries a lower bleeding risk. However, it provides only cytological (cellular) material, which may be insufficient for certain diagnoses requiring tissue architecture assessment. CT Guided Core Biopsy (Trucut Biopsy) uses a larger cutting needle (14-20 gauge) to obtain a core of tissue that preserves histological architecture. This provides a richer tissue sample suitable for histopathology, immunohistochemistry (IHC), molecular profiling, and genomic testing — all increasingly essential for modern targeted cancer therapy selection. The choice between FNAC and core biopsy depends on the lesion location, size, patient factors, and clinical requirements. Why Doctors Recommend CT Guided Biopsy Oncologists, pulmonologists, hepatologists, and other specialists refer patients for the biopsy in Delhi because it is the most reliable way to establish a definitive tissue diagnosis without major surgery. In the modern era of cancer treatment, accurate tissue diagnosis is essential not just to confirm malignancy, but to identify: Cancer type and subtype (adenocarcinoma vs. squamous cell carcinoma vs. SCLC, etc.) Immunohistochemistry (IHC) markers (ER/PR/HER2 for breast cancer, PDL-1 for immunotherapy) Molecular mutations (EGFR, ALK, ROS1, KRAS, BRAF, etc.) for targeted therapy NGS (Next Generation Sequencing) profiling for comprehensive genomic analysis Lymphoma subtyping requiring tissue architecture Non-malignant diagnoses including infections (TB, fungal), sarcoidosis, and autoimmune conditions Conditions Diagnosed by this test Lung Cancer: Lung nodules, masses, and mediastinal lymph nodes Liver Lesions: Hepatocellular carcinoma, liver metastases, cholangiocarcinoma, benign lesions Pancreatic Cancer: Pancreatic masses and lymph nodes Kidney Tumors: Renal cell carcinoma vs. benign oncocytoma Adrenal Lesions: Adrenal metastases vs. adenoma Lymphoma: Lymph node and extranodal lymphoma Bone Lesions: Primary bone tumors and bone metastases Retroperitoneal Masses Spinal Lesions Soft Tissue Masses Infections: Abscess characterization and culture, tuberculosis Carcinoma of Unknown Primary Who Needs CT Guided Biopsy? Your physician may refer you for core needle biopsy in Delhi if: CT, MRI, or PET scan has revealed a suspicious lesion that requires tissue confirmation A lesion is too deep to be biopsied safely by physical examination or ultrasound You have a known cancer and a new lesion has appeared that needs tissue characterization Cancer has returned and repeat biopsy is needed for molecular profiling You need a diagnosis before starting chemotherapy, targeted therapy, or immunotherapy A pulmonary nodule requires tissue diagnosis to determine if it is malignant You have a liver lesion where the diagnosis is uncertain on imaging alone Suspected lymphoma requiring lymph node biopsy Symptoms and Findings That Lead to the procedure Unexplained weight loss with suspicious mass found on imaging Persistent cough or hemoptysis with lung mass on CT Abdominal

The landscape of cancer imaging is continuously evolving, and one of the most exciting recent advances is the Trivehexin PET Scan. Available at Neurad Diagnostics in Delhi, the 68Ga-Trivehexin PET/CT scan represents a breakthrough in integrin-targeted molecular imaging for cancer. By targeting integrin αvβ6 — a protein highly overexpressed in many epithelial cancers but absent in normal adult tissues — the this scan provides a uniquely specific and high-contrast method for cancer detection, staging, and treatment planning. This guide explains everything you need to know about this innovative diagnostic technology. Research published in leading journals endorsed by the Society of Nuclear Medicine and Molecular Imaging (SNMMI) demonstrates the high potential of integrin-targeted PET imaging. The European Association of Nuclear Medicine (EANM) actively supports research in novel molecular imaging tracers including Trivehexin for cancer detection. this imaging test at Neurad Diagnostics Delhi — Advanced integrin-targeted cancer imaging Table of Contents What Is a Trivehexin PET Scan? Why Doctors Recommend the Trivehexin PET Scan Cancers and Conditions Detected by Trivehexin PET Scan Who Needs a Trivehexin PET Scan? Symptoms That May Lead to Trivehexin PET Scan How the this imaging test Procedure Works Preparation Before the the Trivehexin scan Step-by-Step Trivehexin PET Scan Procedure at Neurad Diagnostics Advantages of Trivehexin PET Technology Accuracy and Clinical Benefits Safety Information Cost of Trivehexin PET Scan in Delhi NCR Why Choose Neurad Diagnostics for Trivehexin PET Scan in Delhi? Frequently Asked Questions About this scan 1. What is integrin αvβ6? 2. Is Trivehexin PET better than FDG PET for pancreatic cancer? 3. Can Trivehexin PET detect peritoneal metastases? 4. Which lung cancer type benefits from Trivehexin PET? 5. What is the theranostic use of Trivehexin? 6. Is Trivehexin PET available in India? 7. How does Trivehexin compare to FAPI PET? 8. Is Trivehexin PET safe with chemotherapy? What Is a Trivehexin PET Scan? The the Trivehexin scan, formally known as 68Ga-Trivehexin PET/CT, is an advanced nuclear medicine imaging procedure using a Gallium-68 labelled peptide tracer called Trivehexin — a highly specific ligand engineered to bind to Integrin αvβ6 (alpha-v beta-6 integrin). Integrin αvβ6 is a cell surface receptor that plays a critical role in cancer cell invasion, proliferation, and immune evasion. Crucially, αvβ6 is normally absent or expressed at very low levels in healthy adult epithelial tissues but is massively upregulated in a wide range of epithelial cancers — including pancreatic, lung, colorectal, gastric, cervical, ovarian, and head and neck cancers. This highly cancer-specific expression pattern of αvβ6 makes Trivehexin an exceptionally promising diagnostic target. Because normal adult organs show minimal αvβ6 expression, background signal on the Trivehexin PET image is very low, allowing tumor sites to stand out with excellent contrast. Neurad Diagnostics is among the pioneering centers in Delhi NCR bringing this next-generation integrin imaging technology to patients across India. Why Doctors Recommend the Trivehexin PET Scan Oncologists recommend this PET/CT primarily in clinical situations where conventional imaging provides incomplete or misleading staging information. A key scenario is pancreatic cancer — one of the most challenging cancers to image accurately. Pancreatic ductal adenocarcinoma expresses extremely high levels of αvβ6, and Trivehexin PET has been shown to outperform FDG PET for pancreatic cancer staging, particularly for identifying peritoneal metastases and small lymph node involvement that change resectability assessment. Similarly, for colorectal cancer peritoneal metastases — a critical staging question that determines whether patients are eligible for cytoreductive surgery — Trivehexin PET’s very low abdominal background makes it particularly powerful. For lung adenocarcinoma, which uniformly expresses αvβ6, Trivehexin PET provides precise staging and can distinguish malignant from benign nodules with high confidence. Additionally, αvβ6 expression on cancer cells is being actively investigated as a target for αvβ6-directed radionuclide therapy, making Trivehexin PET a potential theranostic partner for emerging αvβ6-targeted treatments. Cancers and Conditions Detected by Trivehexin PET Scan The the procedure is applicable across multiple αvβ6-expressing cancer types: Pancreatic Ductal Adenocarcinoma: Very high αvβ6 expression — often superior to FDG PET for staging Lung Adenocarcinoma: Uniform αvβ6 expression makes Trivehexin highly effective Colorectal Cancer: Particularly useful for peritoneal metastasis detection Gastric Cancer: High αvβ6 expression in gastric adenocarcinoma Cervical Cancer: αvβ6 strongly expressed in cervical squamous and adenocarcinoma Ovarian Cancer: Useful for peritoneal spread assessment Head and Neck Squamous Cell Carcinoma Esophageal Adenocarcinoma Cholangiocarcinoma (Bile Duct Cancer) Bladder Cancer Who Needs a Trivehexin PET Scan? Your oncologist may recommend a this scan in Delhi in these clinical situations: Staging of pancreatic cancer — particularly to assess resectability and rule out peritoneal metastases Staging of lung adenocarcinoma with suspected mediastinal or distant spread Assessment of colorectal cancer peritoneal carcinomatosis extent before cytoreductive surgery Staging or restaging of any αvβ6-expressing cancer where FDG PET is insufficient Radiotherapy treatment planning requiring precise tumor volume definition Evaluation for αvβ6-targeted radionuclide therapy Carcinoma of unknown primary — to identify the primary tumor site Follow-up after treatment to detect early recurrence Symptoms That May Lead to Trivehexin PET Scan Abdominal pain, particularly epigastric or back pain (suggestive of pancreatic cancer) Jaundice (yellow skin/eyes) — biliary obstruction from pancreatic or bile duct cancer Unexplained weight loss Change in bowel habits Persistent cough or hemoptysis (lung cancer) Abnormal tumour markers (CA 19-9, CEA, SCC) Suspicious findings on CT/MRI requiring molecular characterization Known cancer with suspected but unconfirmed metastatic spread How the this imaging test Procedure Works The Trivehexin PET Scan operates through integrin receptor-mediated targeting. Trivehexin is an engineered bicyclic peptide (developed from the cyclic RGD peptide class) designed with high selectivity and affinity for integrin αvβ6. When labelled with Gallium-68 and injected intravenously, it circulates through the bloodstream and binds with high selectivity to αvβ6-expressing cancer cells throughout the body. The very low αvβ6 expression in normal adult tissues results in minimal background signal, while αvβ6-positive tumors and metastases accumulate the tracer and appear as bright focal areas on PET imaging. The combined PET/CT acquisition provides simultaneous functional (receptor expression) and anatomical (structural) data. This is particularly powerful for challenging anatomical regions like the peritoneum, liver, and pelvis — where other